Advertisement

Immunological Response in Early Brain Injury After SAH

  • Takumi Sozen
  • Reiko Tsuchiyama
  • Yu Hasegawa
  • Hidenori Suzuki
  • Vikram Jadhav
  • Shigeru Nishizawa
  • John H. Zhang
Part of the Acta Neurochirurgica Supplements book series (NEUROCHIRURGICA, volume 110/1)

Abstract

This study summarized the role of inflammation in the early brain injury after subarachnoid hemorrhage. Elevation of cytokines, activation of MMPs and phosphorylation of MAPK contributes to neuronal apoptosis and brain edema. Anti-inflammation may be potential strategy for the prevention and suppression of early brain injury after subarachnoid hemorrhage.

Keywords

Early brain injury Immune Inflammation 

Notes

Acknowledgments

This study was partially supported by grants (NS053407) from the National Institutes of Health to J.H.Z.

References

  1. 1.
    Broderick JP, Brott T, Tomsick T, Miller R, Huster G. Intracerebral hemorrhage more than twice as common as subarachnoid hemorrhage. J Neurosurg. 1993;78:188–91.PubMedCrossRefGoogle Scholar
  2. 2.
    Schievink WI, Riedinger M, Jhutty TK, Simon P. Racial disparities in subarachnoid hemorrhage mortality: Los Angeles County, California, 1985–1998. Neuroepidemiology 2004;23:299–305.Google Scholar
  3. 3.
    Hütter BO, Kreitschmann-Andermahr I, Gilsbach JM. Health-related quality of life after aneurysmal subarachnoid hemorrhage: impacts of bleeding severity, computerized tomography findings, surgery, vasospasm, and neurological grade. J Neurosurg. 2001;94:241–51.PubMedCrossRefGoogle Scholar
  4. 4.
    Cahill J, Calvert JW, Zhang JH. Mechanisms of early brain injury after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2006;26:1341–53.PubMedCrossRefGoogle Scholar
  5. 5.
    Ostrowski RP, Colohan AR, Zhang JH. Molecular mechanisms of early brain injury after subarachnoid hemorrhage. Neurol Res. 2006;28:399–414.PubMedCrossRefGoogle Scholar
  6. 6.
    Sercombe R, Dinh YR, Gomis P. Cerebrovascular inflammation following subarachnoid hemorrhage. Jpn J Pharmacol. 2002;88:227–49.PubMedCrossRefGoogle Scholar
  7. 7.
    McKeating EG, Andrews PJ. Cytokines and adhesion molecules in acute brain injury. Br J Anaesth. 1998;80:77–84.PubMedCrossRefGoogle Scholar
  8. 8.
    Mathiesen T, Andersson B, Loftenius A, von Holst H. Increased interleukin-6 levels in cerebrospinal fluid following subarachnoid hemorrhage. J Neurosurg. 1993;78:562–7.PubMedCrossRefGoogle Scholar
  9. 9.
    Gaetani P, Tartara F, Pignatti P, Tancioni F, Rodriguez y Baena R, De Benedetti F. Cisternal CSF levels of cytokines after subarachnoid hemorrhage. Neurol Res. 1998;20:337–42.PubMedGoogle Scholar
  10. 10.
    Mathiesen T, Edner G, Ulfarsson E, Andersson B. Cerebrospinal fluid interleukin-1 receptor antagonist and tumor necrosis factor-alpha following subarachnoid hemorrhage. J Neurosurg. 1997;87:215–20.PubMedCrossRefGoogle Scholar
  11. 11.
    Allan SM, Tyrrell PJ, Rothwell NJ. Interleukin-1 and neuronal injury. Nat Rev Immunol. 2005;5:629–40.PubMedCrossRefGoogle Scholar
  12. 12.
    Prunell GF, Svendgaard NA, Alkass K, Mathiesen T. Inflammation in the brain after experimental subarachnoid hemorrhage. Neurosurgery 2005;56:1082–92.PubMedGoogle Scholar
  13. 13.
    Kwon KY, Jeon BC. Cytokine levels in cerebrospinal fluid and delayed ischemic deficits in patients with aneurysmal subarachnoid hemorrhage. J Korean Med Sci. 2001;16:774–80.PubMedGoogle Scholar
  14. 14.
    Wolburg H, Lippoldt A. Tight junctions of the blood–brain barrier: development, composition and regulation. Vascul Pharmacol. 2002;38:323–37.PubMedCrossRefGoogle Scholar
  15. 15.
    Yang Y, Estrada EY, Thompson JF, Liu W, Rosenberg GA. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab. 2007;27:697–709.PubMedCrossRefGoogle Scholar
  16. 16.
    Yong VW, Power C, Forsyth P, Edwards DR. Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci. 2001;2:502–11.PubMedCrossRefGoogle Scholar
  17. 17.
    Ruhul Amin AR, Senga T, Oo ML, Thant AA, Hamaguchi M. Secretion of matrix metalloproteinase-9 by the proinflammatory cytokine, IL-1beta: a role for the dual signaling pathways, Akt and Erk. Genes Cells. 2003;8:515–23.PubMedCrossRefGoogle Scholar
  18. 18.
    Vecil GG, Larsen PH, Corley SM, Herx LM, Besson A, Goodyer CG, et al. Interleukin-1 is a key regulator of matrix metalloproteinase-9 expression in human neurons in culture and following mouse brain trauma in vivo. J Neurosci Res. 2000;61:212–24.PubMedCrossRefGoogle Scholar
  19. 19.
    Guan Z, Buckman SY, Miller BW, Springer LD, Morrison AR. Interleukin-1beta-induced cyclooxygenase-2 expression requires activation of both c-Jun NH2-terminal kinase and p38 MAPK signal pathways in rat renal mesangial cells. J Biol Chem. 1998;273:28670–6.PubMedCrossRefGoogle Scholar
  20. 20.
    Larsen CM, Wadt KA, Juhl LF, Andersen HU, Karlsen AE, Su MS, et al. Interleukin-1beta-induced rat pancreatic islet nitric oxide synthesis requires both the p38 and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinases. J Biol Chem. 1998;273:15294–300.PubMedCrossRefGoogle Scholar
  21. 21.
    Wu CY, Hsieh HL, Jou MJ, Yang CM. Involvement of p42/p44 MAPK, p38 MAPK, JNK and nuclear factor-kappa B in interleukin-1beta-induced matrix metalloproteinase-9 expression in rat brain astrocytes. J Neurochem. 2004;90:1477–88.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag/Wien 2011

Authors and Affiliations

  • Takumi Sozen
    • 1
    • 2
  • Reiko Tsuchiyama
    • 3
  • Yu Hasegawa
    • 3
  • Hidenori Suzuki
    • 3
  • Vikram Jadhav
    • 3
  • Shigeru Nishizawa
    • 2
  • John H. Zhang
    • 3
    • 4
  1. 1.Department of NeurosurgeryUniversity of Occupational and Environmental HealthKitakyushuJapan
  2. 2.Department of NeurosurgeryUniversity of Occupational and Environmental HealthJapan
  3. 3.Department of PhysiologyLoma Linda University of MedicineLoma LindaUSA
  4. 4.Department of NeurosurgeryLoma Linda University of MedicineLoma LindaUSA

Personalised recommendations